End of PHE

Resources

Webinar

Registration

Blog

  • Contact Us
  • Follow Us:

Stotler Hayes

Providing Legal Assistance to Health Care Providers

  • Who We Are
  • Practice Areas
  • Employment
  • Resources

6 Things LTC Providers Need to Know About the COVID-19 Vaccine on the Cusp of Its US Approval

Since COVID-19 strong-armed its way to the forefront of the US media in March 2020, we’ve seen hundreds, even thousands of news stories, opinion pieces, and agency reports on related topics ranging from its impact on schools and employment to the CARES Act and other financial support. In the last several weeks, the development of a COVID-19 vaccine, its approval process, distribution priority groups, and the like have dominated headlines, and are weighing heavily on the minds of those in the LTC community – residents, employees, and leaders alike. We’ve outlined a breakdown of what’s happened to date, what’s coming next, and what you need to know.

December Provides the Last Chance for SNFs to Secure Performance-Based Incentive Plan Funding

Back in August, the Department of Health and Human Services announced the Provider Relief Fund, Performance-Based Incentive Plan (“Plan”), allocating up to $2 Billion dollars in relief to the LTC industry.   Plan eligibility is open to nursing homes and skilled nursing facilities that are certified in the state in which they receive CMS reimbursement, and report data to CASPER, NHC, or POS.   Whether, and how much funding is received, is tied to two measures of performance:  1) whether the facility’s COVID-19 infection rate is lower than its county’s rate, and 2) whether the facility’s COVID-19 mortality rate falls below a nationally established performance threshold for mortality among nursing home residents infected with COVID-19.   Eligibility is determined on a monthly basis and is automatically evaluated based on the facility’s submission of data to the CDC; no specific or formal application is required!

Congressional COVID-19 Relief

Since the CARES Act took effect on March 25, 2020, there has been an unrelenting push for the passage of follow-up legislation to provide American businesses and individual citizens with additional Covid-relief.  The Democrat-backed HEROES Act and the Republican HEALS Act emerged as the two competing bills most likely to succeed the CARES Act.  However, to date, a divided Congress has not been able to secure passage of either legislative proposal due to interference from the White House and ongoing disagreements as to the scope of the financial relief to be provided and the degree of the legal immunity to be granted.

Provider Requirement to post Cash Price of COVID-19 Diagnostic Testing pursuant to CARES Act & Potential to Incur Civil Monetary Penalties

All providers should take note of an under the radar provision of the CARES Act, 3202(a) & 3202(b), that requires all providers of diagnostic testing for COVID-19 to publicly post the cash price for such a test on the provider’s website (there are options for public posting if the provider has no website…).  This is important because CMS may impose civil monetary penalties of up to $300/day for violations of this requirement.  HHS has indicated that its goal in this requirement is to ensure transparency to both a) the plans and issuers that must comply under section 3202(a) of the CARES Act (which requires plans and issuers to reimburse any provider of COVID-19 diagnostic testing an amount that equals the negotiated rate, or if no negotiated rate exists, then the cash price of the test), and b) individuals who seek COVID-19 diagnostic testing.

5 Things You Need to Know About The Pharmacy Partnership for Long-Term Care Program

On October 16, 2020, the Centers for Disease Control and Prevention (“CDC”) announced a partnership with the Department of Health and Human Services (“HHS”), the Department of Defense (“DoD”), and pharmacy retailers, CVS and Walgreens, through which COVID-19 vaccines, once available, will be administered to long-term care facility residents and staff nationwide.  The Pharmacy Partnership for Long-Term Care Program (the “Program”) is based on a CDC distribution pilot program that began in August in select states and is intended to provide end-to-end coverage of the COVID-19 vaccination process.

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • Next Page »

Stotler Hayes Group, LLC is a national, boutique law firm focused on optimizing recovery for health care providers through Medicaid, Medicare, private collections, training and education. Our attorneys are licensed in, and represent clients before, federal and state courts and agencies in a majority of states around the country.

In the handful of states where Stotler Hayes Group, LLC does not employ a full-time attorney, referrals are made to local counsel, many of whom we have developed close working relationships with over the years. In those cases, our firm works with local counsel throughout the pendency of the case.

Stotler Hayes Group, LLC,

Principal Office: Pawley’s Island, SC, Phone: 843-235-9871; Fax: 888-497-7390; email: info@stotlerhayes.com

Attorney advertising: Prior results expressed in any content published by Stotler Hayes Group, LLC does not guarantee a similar outcome.

The attorney responsible for the content of this website is Andrea Kirksey, Esq., Executive Director and General Counsel for Stotler Hayes Group, LLC, 297 Willbrook Boulevard,  Pawley’s Island, South Carolina.

She may be contacted at (843) 235-9871, ext. 1002 or at akirksey@stotlerhayes.com.

Home                           Contact Us                    Disclaimer

 

Website Designed by Southern Tide Media